Kangmei Pharmaceutical Co Ltd Strategic Asset Allocation Index
Kangmei Pharmaceutical Co Ltd strategic asset allocation index. Kangmei Pharmaceutical Co Ltd (600518) has a Strategic Asset Allocation Index of 59.4% as of June 2023. Strategic assets (PP&E of CN¥4.07 Billion plus long-term investments of CN¥-) total CN¥4.07 Billion, measured against net assets of CN¥6.86 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible equity quality of Kangmei Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Kangmei Pharmaceutical Co Ltd (2000–2021)
Strategic asset allocation index of Kangmei Pharmaceutical Co Ltd from 2000 to 2021. This chart shows how Kangmei Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2000 to 2021. As of June 2023, the index stands at 59.4%, representing strategic assets of CN¥4.07 Billion against net assets of CN¥6.86 Billion CNY.
Kangmei Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2000–2021)
Kangmei Pharmaceutical Co Ltd strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Kangmei Pharmaceutical Co Ltd from 2000 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Kangmei Pharmaceutical Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 46.6% | CN¥4.64 Billion | CN¥4.64 Billion | CN¥- | CN¥9.97 Billion | ▼ -8.7 pp |
| 2019 | 55.2% | CN¥11.41 Billion | CN¥11.41 Billion | CN¥- | CN¥20.65 Billion | ▲ +9.6 pp |
| 2018 | 45.7% | CN¥11.93 Billion | CN¥11.37 Billion | CN¥556.58 Million | CN¥26.12 Billion | ▲ +16.3 pp |
| 2017 | 29.3% | CN¥8.37 Billion | CN¥7.82 Billion | CN¥543.60 Million | CN¥28.52 Billion | ▲ +6.8 pp |
| 2016 | 22.6% | CN¥6.64 Billion | CN¥6.16 Billion | CN¥474.62 Million | CN¥29.38 Billion | ▼ -6.1 pp |
| 2015 | 28.7% | CN¥5.40 Billion | CN¥4.96 Billion | CN¥437.00 Million | CN¥18.84 Billion | ▲ +0.2 pp |
| 2014 | 28.5% | CN¥4.76 Billion | CN¥4.76 Billion | CN¥- | CN¥16.72 Billion | ▼ -24.5 pp |
| 2013 | 53.0% | CN¥6.38 Billion | CN¥6.38 Billion | CN¥- | CN¥12.03 Billion | ▼ -2.6 pp |
| 2012 | 55.7% | CN¥5.89 Billion | CN¥5.89 Billion | CN¥- | CN¥10.58 Billion | ▼ -1.6 pp |
| 2011 | 57.3% | CN¥5.30 Billion | CN¥5.30 Billion | CN¥- | CN¥9.25 Billion | ▼ -6.5 pp |
| 2010 | 63.8% | CN¥3.14 Billion | CN¥3.14 Billion | CN¥- | CN¥4.93 Billion | ▲ +5.6 pp |
| 2009 | 58.1% | CN¥2.48 Billion | CN¥2.48 Billion | CN¥- | CN¥4.27 Billion | ▼ -3.3 pp |
| 2008 | 61.5% | CN¥1.79 Billion | CN¥1.79 Billion | CN¥- | CN¥2.92 Billion | ▲ +18.7 pp |
| 2007 | 42.8% | CN¥992.14 Million | CN¥992.14 Million | CN¥- | CN¥2.32 Billion | ▼ -18.8 pp |
| 2006 | 61.6% | CN¥711.46 Million | CN¥711.46 Million | CN¥- | CN¥1.16 Billion | ▼ -31.0 pp |
| 2005 | 92.6% | CN¥530.95 Million | CN¥530.95 Million | CN¥- | CN¥573.59 Million | ▲ +12.8 pp |
| 2004 | 79.8% | CN¥408.53 Million | CN¥408.53 Million | CN¥- | CN¥511.88 Million | ▲ +3.0 pp |
| 2003 | 76.8% | CN¥339.83 Million | CN¥339.83 Million | CN¥- | CN¥442.44 Million | ▼ -4.4 pp |
| 2002 | 81.2% | CN¥317.61 Million | CN¥317.61 Million | CN¥- | CN¥391.23 Million | ▲ +31.7 pp |
| 2001 | 49.5% | CN¥180.80 Million | CN¥180.80 Million | CN¥- | CN¥365.10 Million | ▼ -27.9 pp |
| 2000 | 77.4% | CN¥80.51 Million | CN¥80.51 Million | CN¥- | CN¥103.96 Million | — |